A genotype-directed study to optimize dosing of irinotecan according to the UGT1A1 genotype.
Federico Innocenti
Other Remuneration - Mayo Foundation
Ravi Salgia
No relevant relationships to disclose
Jacqueline Ramirez
No relevant relationships to disclose
Linda A. Janisch
No relevant relationships to disclose
Samir D. Undevia
No relevant relationships to disclose
Larry House
No relevant relationships to disclose
Soma Das
No relevant relationships to disclose
Kehua Wu
No relevant relationships to disclose
Michelle Turcich
No relevant relationships to disclose
Robert de Wilton Marsh
No relevant relationships to disclose
Theodore Karrison
No relevant relationships to disclose
Michael L. Maitland
No relevant relationships to disclose
Richard L. Schilsky
Consultant or Advisory Role - GlaxoSmithKline; Merck
Honoraria - GlaxoSmithKline; Merck
Mark J. Ratain
Other Remuneration - Mayo Foundation